Jade Biosciences has reported positive interim data from its Phase I trial studying JADE101, an investigational anti-APRIL monoclonal antibody for IgAN. The post Jade reports interim Phase I results of JADE101 for IgAN appeared first on Hospital Management.
Jade Biosciences has reported positive interim data from its Phase I trial studying JADE101, an investigational anti-APRIL monoclonal antibody for IgAN.The post Jade reports interim Phase I results of JADE101 for IgAN appeared first on Hospital Management.
.png)
